Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Sarcoma, Ewing 1 Pain 1 Osteosarcoma 1 Chondrosarcoma 1 Bone Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 8 Specimen Handling 5 Nivolumab 5 selpercatinib 4 Iodine-124 4 Biopsy 4 binimetinib 3 Iodine-131 3 Cetuximab 3 ulixertinib 2 trametinib 2 pembrolizumab 2 omipalisib 2 larotrectinib 2 defactinib 2 dabrafenib 2 Surveys and Questionnaires 2 Sunitinib 2 Radiosurgery 2 Ipilimumab 2 Immunoglobulin G 2 Gemcitabine 2 Disulfides 2 Cyclophosphamide 2 CTLA-4 Antigen 2 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 tipifarnib 1 temsirolimus 1 sapanisertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × Range of Motion, Articular × 90 days × Clear all

NCT07623005 2026-06-03

PMRT-ThyCa

University of Faisalabad

Phase NA Completed

Pain, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡